# US 12,110,545 B2 · Methods of assessing nuclease cleavage

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 12,110,545 B2
- Document ID: US12110545B2
- Status: Granted
- Kind: B2
- Application number: 16/475,862
- Filed: 2018-01-05
- Published: 2020-07-23
- Granted: 2024-10-08
- Earliest claimed: 2017-01-06
- Assignees: Editas Medicine, Inc.
- Applicants: Editas Medicine, Inc.
- Inventors: Georgia Giannoukos; Christopher Wilson; Dawn Ciulla
- Web page: https://patentgrep.com/patent/US12110545B2

## CPC

- C12Q 1/6869: Methods for sequencing
- G16B 20/50: Mutagenesis
- G16B 30/10: Sequence alignment; Homology search
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

The present disclosure relates to methods of analyzing activity of nucleases, such as ZFNs, TALENs or CRISPR-associated nucleases, in particular their cutting at “off-target” loci.

## Claims

### Claim 1

A method for analyzing cleavage and/or repair events for a site specific nuclease, the method comprising:
(a) contacting a cell or tissue with the site specific nuclease, wherein contacting the cell or tissue with the site specific nuclease results in cleavage and/or repair of genomic DNA in the cell or tissue;
(b) obtaining a genomic DNA sample from the cell or tissue that has been contacted with the site specific nuclease;
(c) contacting the genomic DNA sample with a transposase and a transposon comprising a first detection sequence at the 5′ end of the transposon, under conditions whereby the transposon is inserted into the genomic DNA sample and the genomic DNA sample is fragmented into a plurality of tagmented double-stranded nucleic acid fragments comprising the transposon attached to the 5′ end of the nucleic acid fragments;
(d) amplifying the tagmented nucleic acid fragments using
(i) a first fixed primer comprising a nucleotide sequence complementary to a predetermined location in the genomic DNA and comprising a second detection sequence at its 5′ end, and
(ii) a second selective primer comprising a nucleotide sequence complementary to at least a portion of the first detection sequence,
to form amplified nucleic acid fragments comprising the first detection sequence, the transposon attached to the 5′ end of the nucleic acid fragments, and the second detection sequence;
(e) sequencing the amplified nucleic acid fragments to generate sequencing data; and
(f) analyzing the sequencing data for the cleavage and/or repair events of the site specific nuclease.

### Claim 2 (depends on 1)

The method of claim 1, wherein the first detection sequence comprises a first sequencing tag.

### Claim 3 (depends on 2)

The method of claim 2, wherein step (e) comprises contacting the amplified nucleic acid fragments with a first sequencing primer that hybridizes to the first sequencing tag.

### Claim 4 (depends on 1)

The method of claim 1, wherein the second detection sequence comprises a second sequencing tag.

### Claim 5 (depends on 4)

The method of claim 4, wherein step (e) comprises contacting the amplified nucleic acid fragments with a second sequencing primer that hybridizes to the second sequencing tag.

### Claim 6 (depends on 1)

The method of claim 1, wherein the genomic DNA sample is obtained from a single cell.

### Claim 7 (depends on 1)

The method of claim 1, wherein step (d) comprises using a plurality of first fixed primers, wherein each comprises a nucleotide sequence complementary to a different predetermined location in the genomic DNA.

### Claim 8 (depends on 7)

The method of claim 7, wherein step (d) comprises performing a plurality of amplification reactions, each reaction using a different first fixed primer.

### Claim 9 (depends on 7)

The method of claim 7, wherein each of the plurality of first fixed primers comprises a detection sequence comprising (i) the same sequencing tag and (ii) a unique barcode.

### Claim 10 (depends on 1)

The method of claim 1, wherein the double-stranded nucleic acid fragments comprise about 500 to about 5000 bps.

### Claim 11 (depends on 1)

The method of claim 1, wherein the site-specific nuclease is Cas9.